View Press Releases
-
Abzena Opens a New Biologics Testing Lab to Support Partners Programs
-
Watson-Marlow Fluid Technology Solutions’ new name reflects strategy focused on delivering end-to-end fluid management solutions for customers
Watson-Marlow Fluid Technology Group - part of Spirax-Sarco Engineering plc, a FTSE 100 company - today announces it has changed its name to Watson-Marlow Fluid Technology Solutions (WMFTS). As the company evolves to meet the needs of the sectors in which it operates, following a successful period of global growth, the name change aligns with a strategic commitment to providing end-to-end fluid management solutions for customers.
Apr 10, 2022
-
BioIVT Appoints Jennifer Murphy as Senior Vice President of Global Commercial Operations
Jennifer has more than 16 years’ commercial leadership experience in the diagnostics and life sciences industries.
Apr 10, 2022
-
Connectivity, Sustainability and User Experience to transform packaging and drug delivery in next year: Pharmapack Europe 2022
-
Hataali wins US patent for the use of blockchain in advanced medicinal therapy products
-
Ripple Science and Curavit Clinical Research Sign Partnership Agreement to Accelerate Decentralized Clinical Trials (DCTs)
Ripple Enterprise software to be deployed as part of the digital transformation in clinical trials spearheaded by Curavit.
Apr 11, 2022
-
Rousselot Biomedical announces the world’s first GelMA produced under GMP
/ Rousselot®, Darling Ingredients’ health brand, and the global leader of collagen-based solutions announces the launch of GMP grade GelMA. X-Pure® GelMA is the first gelatin methacryloyl, or GelMA, on the market to be produced under GMP conditions.
Apr 12, 2022
-
BigOmics closes Pre-Series A with additional investment from Eppendorf
BigOmics Analytics, a Swiss biodata analytics startup, announces raising additional funding from Eppendorf, a leading life science company that develops and sells instruments, consumables and services for liquid, sample and cell handling in laboratories worldwide. The additional funding brings the total amount raised so far to CHF 2.7M. It will be used to further develop BigOmics’ platforms, to expand its team and to grow its presence in the market.
Mar 20, 2022
-
TGen Selects MemVerge to Accelerate Idiopathic Pulmonary Fibrosis Research Discovery with Big Memory Technology
Translational Genomics Research Institute (TGen), an affiliate of City of Hope, is using MemVerge Memory Machine Big Memory virtualization software to accelerate time to discovery for Idiopathic Pulmonary Fibrosis (IPF), a disease which affects 100,000 people annually in the U.S. Using MemVerge Big Memory technology, TGen is able to dramatically speed analytical processing by nearly 36% for single-cell RNA sequencing.
Mar 14, 2022
-
Alfa Chemistry Optimizes Supply of Glycerides: Monoglycerides, Diglycerides, Triglycerides
Ever since the launch of a wide range of glycerides in the first quarter of last year, there are increasing in-coming demands for glycerides from clients across the globe. To improve user experience, Alfa Chemistry announces to upgrade and optimize this product line by further diversifying the supply of different types of glycerides, including monoglycerides, diglycerides, triglycerides.
Mar 16, 2022
-
CD Formulation Launches Tailed Solutions for Increased Bioavailability Excipients
In a recent statement, the York-based CRO company CD Formulation announces the launch of tailored solutions for increased bioavailability excipients, which aims to tackle the issue of poor bioavailability, a long-lasting challenge in drug development.
Mar 16, 2022
-
Newly Updated: Alfa Chemistry Introduces Environmental Standards to Achieve Fast and Accurate Environmental Analysis
Famed as a supplier of varieties of analytical reagents, Alfa Chemistry never let its customers down and always put customers’ concerns and needs in the first place. Hence, the company recently introduces environmental standards, which is a step to further diversify its offering of chromatography standards and also in response to the increasing needs for environmental analysis.
Mar 16, 2022
-
Canopy Launches Out of Stealth With $13 Million to Help Oncology Practices Adopt a Proactive Care Delivery Model
Canopy Launches Out of Stealth With $13 Million to Help Oncology Practices Adopt a Proactive Care Delivery Model
Mar 17, 2022
-
Oncology Pharma Company Announces Launch of Equity Crowdfunding Campaign
SciTech Development LLC, an oncology pharmaceuticals company, is pleased to announce its equity crowdfunding campaign on StartEngine.
Mar 19, 2022
-
MicrobioSeq Releases Microbial Transcriptomics for Disease Research and Drug Development
MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a good reputation for providing reliable de novo sequencing, genotyping, microarray, and bioinformatics services. With years of experience in the pharmaceutical and life science sectors, CD Genomics has announced Microbial Transcriptomics solutions, which hold promise in uncovering novel ways to treat disease and improve human health.
Mar 20, 2022
-
Ultralow Input RNA-Seq Service Now Available by CD Genomics RNA Solutions Platform
RNA Solutions is a platform that offers services for the revolutionizing study of RNA, targeting both coding and non-coding RNAs of different physiological functions. The scientists at CD Genomics are ready to help detect various types of RNA via meticulous and integrative approaches. CD Genomics is proud to launch the ultralow input RNA-seq service using leading-edge Illumina sequencing techniques.
Mar 15, 2022
-
VisualDx Celebrates One Year of Project IMPACT at AAD
-
UCare Selects HealthSparq to Power Price Transparency for Individuals and Families
-
STEMart Introduces Acute Systemic Toxicity Testing Service for Medical Devices
STEMart launches Acute Systemic Toxicity testing for the medical device industry.
Mar 22, 2022
-
Amerigo Scientific Introduces the Launch of Polystreptavidin 350
Amerigo Scientific introduces Polystreptavidin 350 for applications in lateral flow, ELISA or CLIA.
Mar 22, 2022